Wolters Kluwer N.V (WKL) Fair Value & Analysis
Industrials · NL · Market cap €13.8B
Fair value as of: Jul 18, 2026
From 25 valuation models · updated 22 days ago
Fair value updated Jul 18, 2026, revised from €94.02 to €94.39 (+0.4%) since Jun 24, 2026. Share price +18.7% over the past month.
A strong business, screening 35% undervalued on our models.
What matters now
- The rarer combination: high quality (78/100) AND below fair value. That earns a closer look rather than a quick verdict.
- A fairly wide model range (€60.00 to €126.93) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 18, 2026.
How to read this chart
60‑month range €55.65 – €173.07 · fair‑value band €60.00 – €126.93 · the €70.08 price screens below the €94.39 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 18, 2026.
Analysis
Wolters Kluwer N.V (WKL) currently trades at €70.08, while our model-based Fair Value estimate is €94.39, implying the stock looks roughly 34.7% undervalued today. The Quality Score stands at 78/100 (high quality), in the Industrials sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Wolters Kluwer N.V generated revenue of €6.1B at a net margin of 21.4%. Revenue grew 1.6% year over year. It earns a return on equity of 111.7%. Net debt stands at €4.2B. Fundamentals as of Jul 18, 2026
Our scenario range runs from €60.00 (bear case) to €126.93 (bull case); at €70.08, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 54% below its 52-week high and 29% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -35% fair-value upside, at 35%, WKL screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 25 models by family
Widest divergence: Growth Earnings (€97.10) versus Asset-Based (€2.40). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 71 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Wolters Kluwer N.V. provides information, software solutions, and services for professionals in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments.
Full company description
Wolters Kluwer N.V. provides information, software solutions, and services for professionals in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally. The company operates through Health; Tax & Accounting; Financial & Corporate Compliance; Legal & Regulatory; and Corporate Performance & ESG segments. The Health segment offers clinical solutions and develops GenAI and agentic solutions to drive better patient care and health outcomes. It serves hospitals, healthcare organizations, clinicians, students, schools, libraries, payers, life sciences, digital health companies, and pharmacies. The Tax & Accounting segment offers AI-powered, cloud-based and on-premise software suites, research solutions to tax and accounting firms; and professional services to support professional workflows, including compliance, audit, and firm management. It also serves businesses, government agencies, and academia. The Financial & Corporate Compliance segment provides financial institutions, corporations, small businesses, and law firms with solutions that enable compliance with ever-changing regulatory and legal obligations, improve efficiency, and help achieve better business outcomes. The Legal & Regulatory segment provides Legal & Regulatory trusted information, insights, and analytics for optimal decisions with accuracy and speed. It serves legal and compliance professionals in law firms, corporate legal departments, universities, and government organizations. The Corporate Performance & ESG segment offers delivers software solutions that support organizations in planning, simulating, and managing financial, sustainability, operational, and risk management activities to drive better outcomes. The company also develops a hosted platform for managing and controlling external legal costs. Wolters Kluwer N.V. was founded in 1836 and is headquartered in Alphen aan den Rijn, the Netherlands.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Wolters Kluwer N.V reported revenue of €6.1B in FY2025 versus €4.8B in FY2021, a compound +6.4%/yr. Reported net income was €1.3B in FY2025, compounding +15.8%/yr from FY2021.
Watch WKL: get an alert when its fair value changes →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Health System Adoption of Wolters Kluwer UpToDate Expert AI Now Reaching Approximately 2,500 U.S. Hospitals and Health Systems
- Wolters Kluwer NV (WOLTF) (H1 2026) Earnings Call Highlights: AI Adoption Drives 5% Organic ...
- Wolters Kluwer 2026 Half-Year Report
- Wolters Kluwer to Help Rural Hospitals and FQHCs Access Top Drug Information and Patient Education Solutions Integrated With Epic
Peer Group
Specialty Business Services · 255 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Business Services median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Business Services stocks, each showing price versus our Fair Value estimate (as of Jul 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Cintas Corporation CTAS | $206.25 | $95.30 | -54% |
| RELX PLC RELX | $33.70 | $32.49 | -4% |
| Thomson Reuters Corporation TRI | C$133.87 | C$70.40 | -47% |
| Copart, Inc CPRT | $27.61 | $28.59 | +4% |
| Global Payments Inc GPN | $80.49 | $69.67 | -13% |
| RB Global, Inc RBA | C$156.43 | C$49.14 | -69% |
| Brambles Limited BXB | A$18.79 | A$12.28 | -35% |
| UL Solutions Inc ULS | $87.76 | $33.62 | -62% |
| Aramark ARMK | $56.74 | $13.73 | -76% |
| Rentokil Initial plc RTO | $30.41 | $19.63 | -35% |
Compare Wolters Kluwer N.V with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is Wolters Kluwer N.V (WKL) overvalued or undervalued?
What is the fair value of WKL?
What is the quality score of WKL?
What is the revenue of Wolters Kluwer N.V (WKL)?
What is the net profit margin of WKL?
Does Wolters Kluwer N.V pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Wolters Kluwer N.V and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.